Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague–Dawley rats

Genistein and ethinyl estradiol (EE 2) were examined in multigenerational reproductive and 2-yr chronic toxicity studies with different exposure durations across generations F 0 through F 4. Sprague–Dawley rats were exposed to genistein (0, 5, 100, or 500 ppm) or EE 2 (0, 2, 10, or 50 ppb). Effects...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reproductive toxicology (Elmsford, N.Y.) N.Y.), 2009-11, Vol.28 (3), p.342-353
Hauptverfasser: Latendresse, John R., Bucci, Thomas J., Olson, Greg, Mellick, Paul, Weis, Constance C., Thorn, Brett, Newbold, Retha R., Delclos, K. Barry
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Genistein and ethinyl estradiol (EE 2) were examined in multigenerational reproductive and 2-yr chronic toxicity studies with different exposure durations across generations F 0 through F 4. Sprague–Dawley rats were exposed to genistein (0, 5, 100, or 500 ppm) or EE 2 (0, 2, 10, or 50 ppb). Effects in the male mammary gland are described here. In the multigeneration studies, mammary hyperplasia was induced by both compounds; the chronic studies had a lower incidence, without proportionate neoplasia. Sexual dimorphism (predominant tubuloalveolar growth in females and lobuloalveolar in males) was retained without feminization in high dose genistein or EE 2. In the continuously exposed generations, mammary hyperplasia was sustained but not amplified, appeared morphologically similar across all generations, and was not carried over into unexposed offspring of previously exposed generations. The hyperplasia in male rats was similar whether induced by genistein or EE 2. Results substantiate and extend previous reports that mammary gland hyperplasia in the male rat is one of the most sensitive markers of estrogenic endocrine disruption.
ISSN:0890-6238
1873-1708
DOI:10.1016/j.reprotox.2009.04.006